Skip to main navigation Skip to search Skip to main content

Comparative PET evaluation of [11C]tariquidar, [11C]elacridar and (R)-[11C]verapamil in doxorubicin-resistant and -sensitive murine breast cancer xenografts

  • Thomas Wanek (Speaker)
  • , Claudia Kuntner
  • , Michael Sauberer
  • , J Stanek
  • , Severin Mairinger
  • , C Höpfner
  • , S Strommer
  • , V Wacheck
  • , Jp Bankstahl
  • , W Löscher
  • , T Erker
  • , M Müller
  • , Oliver Langer

Research output: Chapter in Book or Conference ProceedingsConference Proceedings with Oral Presentation

Original languageEnglish
Title of host publicationNuklearmedizin
Pages46-47
Number of pages2
Publication statusPublished - 2011
EventVorkongress Nuklearmedizin 2011 - Dreiländer Tagung -
Duration: 13 Apr 201116 Apr 2011

Conference

ConferenceVorkongress Nuklearmedizin 2011 - Dreiländer Tagung
Period13/04/1116/04/11

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research Field

  • Former Research Field - Health and Bioresources

Cite this